nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—SLC22A3—prostate cancer	0.407	1	CbGaD
Adefovir Dipivoxil—SLC22A3—Estradiol—prostate cancer	0.0799	0.293	CbGbCtD
Adefovir Dipivoxil—ABCC4—Conjugated Estrogens—prostate cancer	0.0739	0.271	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Conjugated Estrogens—prostate cancer	0.0462	0.169	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Estradiol—prostate cancer	0.0405	0.149	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Conjugated Estrogens—prostate cancer	0.0322	0.118	CbGbCtD
Adefovir Dipivoxil—AK2—prostate gland—prostate cancer	0.00469	0.069	CbGeAlD
Adefovir Dipivoxil—SLC22A8—urine—prostate cancer	0.00377	0.0555	CbGeAlD
Adefovir Dipivoxil—NME1—prostate gland—prostate cancer	0.0036	0.053	CbGeAlD
Adefovir Dipivoxil—AK4—prostate gland—prostate cancer	0.00347	0.0511	CbGeAlD
Adefovir Dipivoxil—NME2—prostate gland—prostate cancer	0.00339	0.0499	CbGeAlD
Adefovir Dipivoxil—AK4—seminal vesicle—prostate cancer	0.00293	0.0432	CbGeAlD
Adefovir Dipivoxil—NME2—epithelium—prostate cancer	0.00249	0.0367	CbGeAlD
Adefovir Dipivoxil—NME1—renal system—prostate cancer	0.00245	0.0361	CbGeAlD
Adefovir Dipivoxil—AK2—bone marrow—prostate cancer	0.00242	0.0356	CbGeAlD
Adefovir Dipivoxil—AK4—renal system—prostate cancer	0.00236	0.0348	CbGeAlD
Adefovir Dipivoxil—AK4—urethra—prostate cancer	0.00232	0.0342	CbGeAlD
Adefovir Dipivoxil—NME2—renal system—prostate cancer	0.00231	0.034	CbGeAlD
Adefovir Dipivoxil—AK2—testis—prostate cancer	0.00207	0.0304	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—prostate cancer	0.00198	0.0291	CbGeAlD
Adefovir Dipivoxil—ABCC5—prostate gland—prostate cancer	0.00197	0.029	CbGeAlD
Adefovir Dipivoxil—NME1—bone marrow—prostate cancer	0.00185	0.0273	CbGeAlD
Adefovir Dipivoxil—NME1—testis—prostate cancer	0.00159	0.0233	CbGeAlD
Adefovir Dipivoxil—AK4—testis—prostate cancer	0.00153	0.0225	CbGeAlD
Adefovir Dipivoxil—AK2—lymph node—prostate cancer	0.0015	0.022	CbGeAlD
Adefovir Dipivoxil—NME2—testis—prostate cancer	0.00149	0.022	CbGeAlD
Adefovir Dipivoxil—SLC22A3—prostate gland—prostate cancer	0.00141	0.0207	CbGeAlD
Adefovir Dipivoxil—ABCC4—prostate gland—prostate cancer	0.00136	0.0201	CbGeAlD
Adefovir Dipivoxil—SLC22A8—prostate gland—prostate cancer	0.00135	0.0199	CbGeAlD
Adefovir Dipivoxil—SLC22A3—seminal vesicle—prostate cancer	0.00119	0.0175	CbGeAlD
Adefovir Dipivoxil—NME1—lymph node—prostate cancer	0.00115	0.0169	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—prostate cancer	0.00111	0.0163	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—prostate cancer	0.00108	0.0159	CbGeAlD
Adefovir Dipivoxil—ABCC5—bone marrow—prostate cancer	0.00101	0.0149	CbGeAlD
Adefovir Dipivoxil—SLC22A3—renal system—prostate cancer	0.00096	0.0141	CbGeAlD
Adefovir Dipivoxil—SLC22A3—urethra—prostate cancer	0.000943	0.0139	CbGeAlD
Adefovir Dipivoxil—ABCC4—renal system—prostate cancer	0.00093	0.0137	CbGeAlD
Adefovir Dipivoxil—SLC22A8—renal system—prostate cancer	0.000923	0.0136	CbGeAlD
Adefovir Dipivoxil—ABCC5—testis—prostate cancer	0.000868	0.0128	CbGeAlD
Adefovir Dipivoxil—NME1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000857	1	CbGdCrCtD
Adefovir Dipivoxil—ABCC4—bone marrow—prostate cancer	0.000703	0.0104	CbGeAlD
Adefovir Dipivoxil—ABCC5—lymph node—prostate cancer	0.000629	0.00926	CbGeAlD
Adefovir Dipivoxil—SLC22A3—testis—prostate cancer	0.00062	0.00913	CbGeAlD
Adefovir Dipivoxil—ABCC4—testis—prostate cancer	0.000601	0.00885	CbGeAlD
Adefovir Dipivoxil—SLC22A3—lymph node—prostate cancer	0.00045	0.00662	CbGeAlD
Adefovir Dipivoxil—ABCC4—lymph node—prostate cancer	0.000436	0.00642	CbGeAlD
Adefovir Dipivoxil—Renal failure—Capecitabine—prostate cancer	0.000152	0.000964	CcSEcCtD
Adefovir Dipivoxil—Headache—Ethinyl Estradiol—prostate cancer	0.000152	0.000963	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Prednisone—prostate cancer	0.000151	0.00096	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Docetaxel—prostate cancer	0.000151	0.000958	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Capecitabine—prostate cancer	0.00015	0.000956	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Doxorubicin—prostate cancer	0.000148	0.000938	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Capecitabine—prostate cancer	0.000147	0.000935	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Epirubicin—prostate cancer	0.000147	0.000931	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Capecitabine—prostate cancer	0.000146	0.000927	CcSEcCtD
Adefovir Dipivoxil—Back pain—Etoposide—prostate cancer	0.000145	0.000921	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000144	0.000915	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000144	0.000914	CcSEcCtD
Adefovir Dipivoxil—Nausea—Ethinyl Estradiol—prostate cancer	0.000144	0.000913	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Doxorubicin—prostate cancer	0.000144	0.000913	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Docetaxel—prostate cancer	0.000143	0.000909	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Goserelin—prostate cancer	0.000143	0.000908	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Mitoxantrone—prostate cancer	0.000143	0.000908	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Docetaxel—prostate cancer	0.000142	0.000902	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Conjugated Estrogens—prostate cancer	0.000141	0.000899	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Docetaxel—prostate cancer	0.000141	0.000898	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Goserelin—prostate cancer	0.000141	0.000895	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Docetaxel—prostate cancer	0.000141	0.000893	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Docetaxel—prostate cancer	0.00014	0.000891	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Mitoxantrone—prostate cancer	0.00014	0.000891	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Conjugated Estrogens—prostate cancer	0.00014	0.000886	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Prednisone—prostate cancer	0.000139	0.000886	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Estradiol—prostate cancer	0.000139	0.000883	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Capecitabine—prostate cancer	0.000139	0.00088	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Etoposide—prostate cancer	0.000139	0.00088	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Capecitabine—prostate cancer	0.000137	0.000874	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Estradiol—prostate cancer	0.000137	0.000872	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Capecitabine—prostate cancer	0.000137	0.000869	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Estradiol—prostate cancer	0.000136	0.000866	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Goserelin—prostate cancer	0.000136	0.000865	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Capecitabine—prostate cancer	0.000136	0.000865	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Capecitabine—prostate cancer	0.000136	0.000863	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Doxorubicin—prostate cancer	0.000136	0.000862	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000135	0.000857	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000134	0.000851	CcSEcCtD
Adefovir Dipivoxil—Cough—Etoposide—prostate cancer	0.000131	0.000831	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Epirubicin—prostate cancer	0.000131	0.00083	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Mitoxantrone—prostate cancer	0.000129	0.000822	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Estradiol—prostate cancer	0.000129	0.00082	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Epirubicin—prostate cancer	0.000129	0.000818	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Mitoxantrone—prostate cancer	0.000128	0.000812	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Etoposide—prostate cancer	0.000128	0.000811	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000127	0.000805	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Goserelin—prostate cancer	0.000127	0.000804	CcSEcCtD
Adefovir Dipivoxil—Rash—Goserelin—prostate cancer	0.000126	0.000798	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Goserelin—prostate cancer	0.000125	0.000797	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Conjugated Estrogens—prostate cancer	0.000125	0.000797	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Estradiol—prostate cancer	0.000125	0.000793	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Estradiol—prostate cancer	0.000125	0.000793	CcSEcCtD
Adefovir Dipivoxil—Headache—Goserelin—prostate cancer	0.000125	0.000792	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Docetaxel—prostate cancer	0.000125	0.000791	CcSEcCtD
Adefovir Dipivoxil—Rash—Conjugated Estrogens—prostate cancer	0.000124	0.00079	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Conjugated Estrogens—prostate cancer	0.000124	0.000789	CcSEcCtD
Adefovir Dipivoxil—Headache—Conjugated Estrogens—prostate cancer	0.000124	0.000785	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—prostate cancer	0.000123	0.000782	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Prednisone—prostate cancer	0.000121	0.00077	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—prostate cancer	0.000121	0.000768	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Capecitabine—prostate cancer	0.000121	0.000766	CcSEcCtD
Adefovir Dipivoxil—Back pain—Docetaxel—prostate cancer	0.00012	0.000765	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.00012	0.000764	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Etoposide—prostate cancer	0.00012	0.000761	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—prostate cancer	0.000119	0.000757	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Capecitabine—prostate cancer	0.000119	0.000755	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Etoposide—prostate cancer	0.000119	0.000755	CcSEcCtD
Adefovir Dipivoxil—Nausea—Goserelin—prostate cancer	0.000118	0.000751	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—prostate cancer	0.000118	0.000751	CcSEcCtD
Adefovir Dipivoxil—Nausea—Conjugated Estrogens—prostate cancer	0.000117	0.000744	CcSEcCtD
Adefovir Dipivoxil—Back pain—Capecitabine—prostate cancer	0.000117	0.000741	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Etoposide—prostate cancer	0.000117	0.000741	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Mitoxantrone—prostate cancer	0.000116	0.000739	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Mitoxantrone—prostate cancer	0.000116	0.000739	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Docetaxel—prostate cancer	0.000115	0.000731	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000114	0.000723	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Estradiol—prostate cancer	0.000113	0.000719	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Estradiol—prostate cancer	0.000112	0.000709	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Capecitabine—prostate cancer	0.000111	0.000708	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—prostate cancer	0.000109	0.000695	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—prostate cancer	0.000109	0.000693	CcSEcCtD
Adefovir Dipivoxil—Cough—Docetaxel—prostate cancer	0.000109	0.000691	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Estradiol—prostate cancer	0.000108	0.000686	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Prednisone—prostate cancer	0.000107	0.000682	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Etoposide—prostate cancer	0.000106	0.000676	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Docetaxel—prostate cancer	0.000106	0.000674	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Docetaxel—prostate cancer	0.000106	0.000674	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Epirubicin—prostate cancer	0.000106	0.000671	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Etoposide—prostate cancer	0.000106	0.000671	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Mitoxantrone—prostate cancer	0.000106	0.00067	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000105	0.000669	CcSEcCtD
Adefovir Dipivoxil—Cough—Capecitabine—prostate cancer	0.000105	0.000669	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—prostate cancer	0.000105	0.000666	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Capecitabine—prostate cancer	0.000103	0.000652	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Capecitabine—prostate cancer	0.000103	0.000652	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Epirubicin—prostate cancer	0.000103	0.000651	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000102	0.000648	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—prostate cancer	0.000102	0.000646	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—prostate cancer	0.000101	0.000641	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—prostate cancer	0.000101	0.000641	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Mitoxantrone—prostate cancer	0.000101	0.000639	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Estradiol—prostate cancer	0.0001	0.000638	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Etoposide—prostate cancer	0.0001	0.000635	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Docetaxel—prostate cancer	9.97e-05	0.000633	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Docetaxel—prostate cancer	9.95e-05	0.000632	CcSEcCtD
Adefovir Dipivoxil—Rash—Estradiol—prostate cancer	9.95e-05	0.000632	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Estradiol—prostate cancer	9.94e-05	0.000632	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Prednisone—prostate cancer	9.93e-05	0.000631	CcSEcCtD
Adefovir Dipivoxil—Headache—Estradiol—prostate cancer	9.89e-05	0.000628	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Docetaxel—prostate cancer	9.87e-05	0.000627	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Doxorubicin—prostate cancer	9.78e-05	0.000621	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—prostate cancer	9.7e-05	0.000616	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Docetaxel—prostate cancer	9.69e-05	0.000616	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Etoposide—prostate cancer	9.67e-05	0.000614	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Etoposide—prostate cancer	9.67e-05	0.000614	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Capecitabine—prostate cancer	9.65e-05	0.000613	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Epirubicin—prostate cancer	9.65e-05	0.000613	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Capecitabine—prostate cancer	9.64e-05	0.000612	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—prostate cancer	9.58e-05	0.000609	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Capecitabine—prostate cancer	9.56e-05	0.000607	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—prostate cancer	9.53e-05	0.000606	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Doxorubicin—prostate cancer	9.48e-05	0.000603	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—prostate cancer	9.48e-05	0.000603	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—prostate cancer	9.46e-05	0.000601	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—prostate cancer	9.41e-05	0.000598	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Capecitabine—prostate cancer	9.38e-05	0.000596	CcSEcCtD
Adefovir Dipivoxil—Nausea—Estradiol—prostate cancer	9.37e-05	0.000596	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Mitoxantrone—prostate cancer	9.35e-05	0.000594	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—prostate cancer	9.33e-05	0.000593	CcSEcCtD
Adefovir Dipivoxil—Rash—Mitoxantrone—prostate cancer	9.27e-05	0.000589	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mitoxantrone—prostate cancer	9.26e-05	0.000589	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.26e-05	0.000588	CcSEcCtD
Adefovir Dipivoxil—Headache—Mitoxantrone—prostate cancer	9.21e-05	0.000585	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Prednisone—prostate cancer	9.14e-05	0.000581	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	9.08e-05	0.000577	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.97e-05	0.00057	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Docetaxel—prostate cancer	8.95e-05	0.000569	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—prostate cancer	8.93e-05	0.000567	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—prostate cancer	8.86e-05	0.000563	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Docetaxel—prostate cancer	8.84e-05	0.000561	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—prostate cancer	8.82e-05	0.00056	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Docetaxel—prostate cancer	8.78e-05	0.000558	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Etoposide—prostate cancer	8.78e-05	0.000558	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—prostate cancer	8.77e-05	0.000558	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—prostate cancer	8.75e-05	0.000556	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mitoxantrone—prostate cancer	8.73e-05	0.000555	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Capecitabine—prostate cancer	8.66e-05	0.00055	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Etoposide—prostate cancer	8.65e-05	0.00055	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Prednisone—prostate cancer	8.6e-05	0.000546	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Capecitabine—prostate cancer	8.56e-05	0.000544	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Prednisone—prostate cancer	8.52e-05	0.000541	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Capecitabine—prostate cancer	8.5e-05	0.00054	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Epirubicin—prostate cancer	8.4e-05	0.000534	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Etoposide—prostate cancer	8.37e-05	0.000532	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Prednisone—prostate cancer	8.36e-05	0.000531	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Docetaxel—prostate cancer	8.31e-05	0.000528	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—prostate cancer	8.28e-05	0.000526	CcSEcCtD
Adefovir Dipivoxil—Back pain—Epirubicin—prostate cancer	8.13e-05	0.000516	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Capecitabine—prostate cancer	8.05e-05	0.000511	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Docetaxel—prostate cancer	8.04e-05	0.000511	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Docetaxel—prostate cancer	8.04e-05	0.000511	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Prednisone—prostate cancer	7.99e-05	0.000507	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Capecitabine—prostate cancer	7.78e-05	0.000494	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Capecitabine—prostate cancer	7.78e-05	0.000494	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Etoposide—prostate cancer	7.78e-05	0.000494	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—prostate cancer	7.77e-05	0.000494	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—prostate cancer	7.76e-05	0.000493	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Prednisone—prostate cancer	7.72e-05	0.00049	CcSEcCtD
Adefovir Dipivoxil—Rash—Etoposide—prostate cancer	7.71e-05	0.00049	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Etoposide—prostate cancer	7.71e-05	0.00049	CcSEcCtD
Adefovir Dipivoxil—Headache—Etoposide—prostate cancer	7.66e-05	0.000487	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—prostate cancer	7.66e-05	0.000487	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Prednisone—prostate cancer	7.62e-05	0.000484	CcSEcCtD
Adefovir Dipivoxil—Back pain—Doxorubicin—prostate cancer	7.52e-05	0.000478	CcSEcCtD
Adefovir Dipivoxil—Cough—Epirubicin—prostate cancer	7.33e-05	0.000466	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Docetaxel—prostate cancer	7.29e-05	0.000463	CcSEcCtD
Adefovir Dipivoxil—Nausea—Etoposide—prostate cancer	7.27e-05	0.000462	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Docetaxel—prostate cancer	7.19e-05	0.000457	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Doxorubicin—prostate cancer	7.18e-05	0.000456	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Prednisone—prostate cancer	7.17e-05	0.000455	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—prostate cancer	7.15e-05	0.000454	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—prostate cancer	7.15e-05	0.000454	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.1e-05	0.000451	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Capecitabine—prostate cancer	7.06e-05	0.000449	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Capecitabine—prostate cancer	6.96e-05	0.000442	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Docetaxel—prostate cancer	6.96e-05	0.000442	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Prednisone—prostate cancer	6.93e-05	0.00044	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Prednisone—prostate cancer	6.93e-05	0.00044	CcSEcCtD
Adefovir Dipivoxil—Cough—Doxorubicin—prostate cancer	6.78e-05	0.000431	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Capecitabine—prostate cancer	6.73e-05	0.000428	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—prostate cancer	6.72e-05	0.000427	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—prostate cancer	6.71e-05	0.000427	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—prostate cancer	6.66e-05	0.000423	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Doxorubicin—prostate cancer	6.62e-05	0.00042	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—prostate cancer	6.62e-05	0.00042	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.57e-05	0.000418	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Epirubicin—prostate cancer	6.54e-05	0.000415	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Docetaxel—prostate cancer	6.46e-05	0.000411	CcSEcCtD
Adefovir Dipivoxil—Rash—Docetaxel—prostate cancer	6.41e-05	0.000407	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Docetaxel—prostate cancer	6.4e-05	0.000407	CcSEcCtD
Adefovir Dipivoxil—Headache—Docetaxel—prostate cancer	6.37e-05	0.000405	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Prednisone—prostate cancer	6.29e-05	0.0004	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Capecitabine—prostate cancer	6.26e-05	0.000398	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.25e-05	0.000397	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—prostate cancer	6.22e-05	0.000395	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—prostate cancer	6.21e-05	0.000395	CcSEcCtD
Adefovir Dipivoxil—Rash—Capecitabine—prostate cancer	6.21e-05	0.000394	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Prednisone—prostate cancer	6.2e-05	0.000394	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Capecitabine—prostate cancer	6.2e-05	0.000394	CcSEcCtD
Adefovir Dipivoxil—Headache—Capecitabine—prostate cancer	6.17e-05	0.000392	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—prostate cancer	6.16e-05	0.000392	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Doxorubicin—prostate cancer	6.05e-05	0.000384	CcSEcCtD
Adefovir Dipivoxil—Nausea—Docetaxel—prostate cancer	6.04e-05	0.000384	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—prostate cancer	6.04e-05	0.000383	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Prednisone—prostate cancer	6e-05	0.000381	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—prostate cancer	5.96e-05	0.000379	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—prostate cancer	5.92e-05	0.000376	CcSEcCtD
Adefovir Dipivoxil—Nausea—Capecitabine—prostate cancer	5.85e-05	0.000371	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.78e-05	0.000367	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—prostate cancer	5.61e-05	0.000356	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—prostate cancer	5.58e-05	0.000355	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Prednisone—prostate cancer	5.57e-05	0.000354	CcSEcCtD
Adefovir Dipivoxil—Rash—Prednisone—prostate cancer	5.53e-05	0.000351	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisone—prostate cancer	5.52e-05	0.000351	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—prostate cancer	5.51e-05	0.00035	CcSEcCtD
Adefovir Dipivoxil—Headache—Prednisone—prostate cancer	5.49e-05	0.000349	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.48e-05	0.000348	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—prostate cancer	5.42e-05	0.000344	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—prostate cancer	5.42e-05	0.000344	CcSEcCtD
Adefovir Dipivoxil—Nausea—Prednisone—prostate cancer	5.21e-05	0.000331	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—prostate cancer	5.19e-05	0.00033	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—prostate cancer	5.02e-05	0.000319	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—prostate cancer	5.02e-05	0.000319	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Epirubicin—prostate cancer	4.92e-05	0.000313	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Epirubicin—prostate cancer	4.85e-05	0.000308	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—prostate cancer	4.69e-05	0.000298	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Doxorubicin—prostate cancer	4.55e-05	0.000289	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Doxorubicin—prostate cancer	4.49e-05	0.000285	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Epirubicin—prostate cancer	4.36e-05	0.000277	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—prostate cancer	4.34e-05	0.000276	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—prostate cancer	4.32e-05	0.000275	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—prostate cancer	4.32e-05	0.000274	CcSEcCtD
Adefovir Dipivoxil—Headache—Epirubicin—prostate cancer	4.3e-05	0.000273	CcSEcCtD
Adefovir Dipivoxil—Nausea—Epirubicin—prostate cancer	4.07e-05	0.000259	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Doxorubicin—prostate cancer	4.03e-05	0.000256	CcSEcCtD
Adefovir Dipivoxil—Rash—Doxorubicin—prostate cancer	4e-05	0.000254	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—prostate cancer	4e-05	0.000254	CcSEcCtD
Adefovir Dipivoxil—Headache—Doxorubicin—prostate cancer	3.97e-05	0.000253	CcSEcCtD
Adefovir Dipivoxil—Nausea—Doxorubicin—prostate cancer	3.77e-05	0.000239	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—UCP3—prostate cancer	2.41e-05	0.000255	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TCN2—prostate cancer	2.41e-05	0.000255	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA3—prostate cancer	2.41e-05	0.000255	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—P4HB—prostate cancer	2.4e-05	0.000254	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VAV3—prostate cancer	2.38e-05	0.000252	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	2.38e-05	0.000252	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFB1—prostate cancer	2.38e-05	0.000252	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—TYMS—prostate cancer	2.36e-05	0.00025	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC22A1—prostate cancer	2.34e-05	0.000247	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTM1—prostate cancer	2.34e-05	0.000247	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—PPARA—prostate cancer	2.33e-05	0.000247	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.32e-05	0.000246	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—B2M—prostate cancer	2.31e-05	0.000245	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFBR1—prostate cancer	2.31e-05	0.000245	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ITPR1—prostate cancer	2.31e-05	0.000245	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.3e-05	0.000244	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HSD3B1—prostate cancer	2.3e-05	0.000243	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—LPL—prostate cancer	2.29e-05	0.000243	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CG—prostate cancer	2.29e-05	0.000242	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SULT2A1—prostate cancer	2.28e-05	0.000241	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKR1C3—prostate cancer	2.27e-05	0.000241	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RPS19—prostate cancer	2.27e-05	0.000241	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PRKACB—prostate cancer	2.26e-05	0.00024	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MED12—prostate cancer	2.24e-05	0.000237	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.23e-05	0.000236	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GNG5—prostate cancer	2.22e-05	0.000235	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP1A1—prostate cancer	2.21e-05	0.000234	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	2.21e-05	0.000234	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PPP3CA—prostate cancer	2.2e-05	0.000233	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TBXAS1—prostate cancer	2.2e-05	0.000233	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA4—prostate cancer	2.2e-05	0.000233	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ERCC2—prostate cancer	2.2e-05	0.000233	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.19e-05	0.000232	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—prostate cancer	2.19e-05	0.000232	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2—prostate cancer	2.19e-05	0.000231	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—INS—prostate cancer	2.17e-05	0.000229	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA2—prostate cancer	2.15e-05	0.000227	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOA3—prostate cancer	2.14e-05	0.000227	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PRKCZ—prostate cancer	2.13e-05	0.000226	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CREBBP—prostate cancer	2.12e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SULT1A1—prostate cancer	2.12e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ABCG5—prostate cancer	2.12e-05	0.000225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—RXRA—prostate cancer	2.12e-05	0.000224	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALR—prostate cancer	2.09e-05	0.000222	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—EP300—prostate cancer	2.08e-05	0.000221	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTA1—prostate cancer	2.07e-05	0.000219	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—MTHFR—prostate cancer	2.06e-05	0.000219	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PARP1—prostate cancer	2.06e-05	0.000218	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGFR4—prostate cancer	2.06e-05	0.000218	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NAT2—prostate cancer	2.05e-05	0.000217	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTO1—prostate cancer	2.05e-05	0.000217	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HSD3B2—prostate cancer	2.05e-05	0.000217	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ITGB3—prostate cancer	2.04e-05	0.000216	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—HPGDS—prostate cancer	2.04e-05	0.000216	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CALCA—prostate cancer	2.03e-05	0.000215	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP2C19—prostate cancer	2.03e-05	0.000215	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PPARA—prostate cancer	2.02e-05	0.000214	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CD—prostate cancer	2.01e-05	0.000213	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ACHE—prostate cancer	1.98e-05	0.00021	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTT1—prostate cancer	1.98e-05	0.00021	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PLCB2—prostate cancer	1.96e-05	0.000208	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—LRP2—prostate cancer	1.96e-05	0.000208	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP2C18—prostate cancer	1.96e-05	0.000208	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP2A6—prostate cancer	1.96e-05	0.000207	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HSPA1A—prostate cancer	1.95e-05	0.000207	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.94e-05	0.000205	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—P4HB—prostate cancer	1.93e-05	0.000204	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SRC—prostate cancer	1.91e-05	0.000202	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKR1C3—prostate cancer	1.9e-05	0.000202	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CAV1—prostate cancer	1.9e-05	0.000202	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—NOS3—prostate cancer	1.9e-05	0.000201	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PRKACB—prostate cancer	1.89e-05	0.000201	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP17A1—prostate cancer	1.87e-05	0.000199	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC22A1—prostate cancer	1.87e-05	0.000198	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—PPARA—prostate cancer	1.87e-05	0.000198	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CASP9—prostate cancer	1.87e-05	0.000198	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	1.86e-05	0.000197	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.85e-05	0.000196	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	1.84e-05	0.000195	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SULT2A1—prostate cancer	1.83e-05	0.000193	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PRKCQ—prostate cancer	1.81e-05	0.000192	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLAU—prostate cancer	1.8e-05	0.000191	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MED12—prostate cancer	1.8e-05	0.00019	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOA2—prostate cancer	1.79e-05	0.000189	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GNG5—prostate cancer	1.78e-05	0.000189	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CAV1—prostate cancer	1.76e-05	0.000186	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CB—prostate cancer	1.75e-05	0.000186	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—prostate cancer	1.74e-05	0.000184	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CG—prostate cancer	1.73e-05	0.000184	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF10—prostate cancer	1.72e-05	0.000182	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOA3—prostate cancer	1.72e-05	0.000182	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	1.7e-05	0.000181	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SLC5A5—prostate cancer	1.7e-05	0.00018	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	1.69e-05	0.000179	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP2E1—prostate cancer	1.66e-05	0.000176	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NQO1—prostate cancer	1.65e-05	0.000174	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—INS—prostate cancer	1.64e-05	0.000174	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFBR2—prostate cancer	1.64e-05	0.000174	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—HPGDS—prostate cancer	1.64e-05	0.000173	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP2C19—prostate cancer	1.63e-05	0.000172	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TH—prostate cancer	1.62e-05	0.000172	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—PPARA—prostate cancer	1.62e-05	0.000171	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ITPR1—prostate cancer	1.61e-05	0.000171	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CREBBP—prostate cancer	1.61e-05	0.00017	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP3A4—prostate cancer	1.6e-05	0.00017	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CG—prostate cancer	1.6e-05	0.00017	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ACHE—prostate cancer	1.59e-05	0.000168	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTT1—prostate cancer	1.59e-05	0.000168	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—EGF—prostate cancer	1.58e-05	0.000168	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1B1—prostate cancer	1.58e-05	0.000167	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP2A6—prostate cancer	1.57e-05	0.000166	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—prostate cancer	1.54e-05	0.000163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GGT1—prostate cancer	1.53e-05	0.000162	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKR1C3—prostate cancer	1.53e-05	0.000162	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CD—prostate cancer	1.52e-05	0.000161	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PRKACB—prostate cancer	1.52e-05	0.000161	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—prostate cancer	1.51e-05	0.00016	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NCOA1—prostate cancer	1.5e-05	0.000159	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP17A1—prostate cancer	1.5e-05	0.000159	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.49e-05	0.000157	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—CREBBP—prostate cancer	1.48e-05	0.000157	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP19A1—prostate cancer	1.48e-05	0.000157	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—LPL—prostate cancer	1.48e-05	0.000157	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IGF1—prostate cancer	1.47e-05	0.000155	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PDGFRB—prostate cancer	1.46e-05	0.000155	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.45e-05	0.000154	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—EP300—prostate cancer	1.44e-05	0.000153	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—NOS3—prostate cancer	1.44e-05	0.000152	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOA2—prostate cancer	1.43e-05	0.000152	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—RXRA—prostate cancer	1.43e-05	0.000152	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERCC2—prostate cancer	1.42e-05	0.00015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	1.41e-05	0.000149	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CD—prostate cancer	1.41e-05	0.000149	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SERPINE1—prostate cancer	1.39e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB3—prostate cancer	1.38e-05	0.000147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGFR2—prostate cancer	1.38e-05	0.000146	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—COMT—prostate cancer	1.38e-05	0.000146	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTP1—prostate cancer	1.37e-05	0.000145	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—SLC5A5—prostate cancer	1.37e-05	0.000145	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ITPR1—prostate cancer	1.35e-05	0.000143	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.34e-05	0.000142	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP2E1—prostate cancer	1.33e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTHFR—prostate cancer	1.33e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NOS3—prostate cancer	1.33e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CB—prostate cancer	1.33e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TERT—prostate cancer	1.33e-05	0.000141	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NQO1—prostate cancer	1.32e-05	0.00014	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—prostate cancer	1.32e-05	0.000139	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TH—prostate cancer	1.3e-05	0.000138	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—JAK2—prostate cancer	1.29e-05	0.000137	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP3A4—prostate cancer	1.29e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.28e-05	0.000136	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—TYMS—prostate cancer	1.28e-05	0.000135	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HIF1A—prostate cancer	1.27e-05	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1B1—prostate cancer	1.27e-05	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTM1—prostate cancer	1.26e-05	0.000134	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—prostate cancer	1.26e-05	0.000133	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—LPL—prostate cancer	1.24e-05	0.000131	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CAV1—prostate cancer	1.23e-05	0.00013	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CB—prostate cancer	1.23e-05	0.00013	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GGT1—prostate cancer	1.23e-05	0.00013	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NCOA1—prostate cancer	1.21e-05	0.000128	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP1A1—prostate cancer	1.2e-05	0.000127	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP19A1—prostate cancer	1.19e-05	0.000126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ERCC2—prostate cancer	1.19e-05	0.000126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.19e-05	0.000126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—BAD—prostate cancer	1.15e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—prostate cancer	1.15e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—RXRA—prostate cancer	1.15e-05	0.000122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2—prostate cancer	1.13e-05	0.000119	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.12e-05	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—APC—prostate cancer	1.12e-05	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTHFR—prostate cancer	1.11e-05	0.000118	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—COMT—prostate cancer	1.11e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGF—prostate cancer	1.11e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IRS1—prostate cancer	1.11e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTP1—prostate cancer	1.1e-05	0.000117	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—EP300—prostate cancer	1.09e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PPARA—prostate cancer	1.09e-05	0.000116	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ITPR1—prostate cancer	1.08e-05	0.000115	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GSK3B—prostate cancer	1.07e-05	0.000114	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—prostate cancer	1.07e-05	0.000113	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—INS—prostate cancer	1.06e-05	0.000112	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CREBBP—prostate cancer	1.04e-05	0.00011	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CAV1—prostate cancer	1.03e-05	0.000109	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—TYMS—prostate cancer	1.02e-05	0.000108	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTM1—prostate cancer	1.01e-05	0.000107	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—EP300—prostate cancer	1.01e-05	0.000107	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—LPL—prostate cancer	9.93e-06	0.000105	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MAP2K1—prostate cancer	9.89e-06	0.000105	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SRC—prostate cancer	9.83e-06	0.000104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CD—prostate cancer	9.83e-06	0.000104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SERPINE1—prostate cancer	9.72e-06	0.000103	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP1A1—prostate cancer	9.59e-06	0.000102	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—prostate cancer	9.57e-06	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ERCC2—prostate cancer	9.51e-06	0.000101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGF2—prostate cancer	9.41e-06	9.97e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CG—prostate cancer	9.36e-06	9.92e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NOS3—prostate cancer	9.28e-06	9.83e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—JAK2—prostate cancer	9.02e-06	9.56e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTHFR—prostate cancer	8.94e-06	9.47e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—INS—prostate cancer	8.86e-06	9.39e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MDM2—prostate cancer	8.81e-06	9.33e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TGFB1—prostate cancer	8.79e-06	9.31e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PPARA—prostate cancer	8.77e-06	9.29e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—prostate cancer	8.73e-06	9.25e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CREBBP—prostate cancer	8.68e-06	9.2e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB2—prostate cancer	8.68e-06	9.2e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CB—prostate cancer	8.57e-06	9.07e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—prostate cancer	8.49e-06	8.99e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CAV1—prostate cancer	8.25e-06	8.73e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CD—prostate cancer	8.23e-06	8.72e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KRAS—prostate cancer	8.14e-06	8.62e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—prostate cancer	8.1e-06	8.58e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1B—prostate cancer	8.04e-06	8.52e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—NOS3—prostate cancer	7.77e-06	8.23e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CTNNB1—prostate cancer	7.6e-06	8.05e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CG—prostate cancer	7.51e-06	7.96e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—prostate cancer	7.48e-06	7.92e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1A—prostate cancer	7.42e-06	7.86e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—prostate cancer	7.4e-06	7.84e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—prostate cancer	7.23e-06	7.66e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CB—prostate cancer	7.17e-06	7.6e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—prostate cancer	7.11e-06	7.53e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—INS—prostate cancer	7.11e-06	7.53e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EP300—prostate cancer	7.06e-06	7.48e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CREBBP—prostate cancer	6.96e-06	7.38e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SRC—prostate cancer	6.87e-06	7.27e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—prostate cancer	6.62e-06	7.01e-05	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—prostate cancer	6.62e-06	7.01e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CD—prostate cancer	6.6e-06	6.99e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NOS3—prostate cancer	6.23e-06	6.6e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—prostate cancer	6.2e-06	6.57e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MYC—prostate cancer	6.15e-06	6.52e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFB1—prostate cancer	6.14e-06	6.5e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—prostate cancer	6.11e-06	6.47e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—prostate cancer	6.02e-06	6.37e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—EP300—prostate cancer	5.91e-06	6.26e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CB—prostate cancer	5.75e-06	6.1e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—prostate cancer	5.7e-06	6.04e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KRAS—prostate cancer	5.68e-06	6.02e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—prostate cancer	5.22e-06	5.53e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—prostate cancer	4.97e-06	5.27e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—EP300—prostate cancer	4.74e-06	5.02e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—prostate cancer	4.62e-06	4.9e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—prostate cancer	4.37e-06	4.63e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—prostate cancer	4.27e-06	4.52e-05	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—prostate cancer	3.57e-06	3.78e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—prostate cancer	3.51e-06	3.72e-05	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—prostate cancer	2.87e-06	3.04e-05	CbGpPWpGaD
